Pharma-Bio Serv increased quarterly Revenue by approximately $0.4 million to $2.3 million and reported a $14 thousand net loss, an improvement of approximately $190 thousand. Investors also saw nine-month Net Income reach approximately $252 thousand, with the company citing improved financial performance and confidence heading into the final quarter.

Key Highlights

  • Nine-month revenue reached approximately $7.3 million, up approximately $0.5 million from the corresponding period.
  • Nine-month net income was approximately $252 thousand, an improvement of approximately $352 thousand.
  • Chief Executive Officer Victor Sanchez said Pharma-Bio Serv remained confident it could build on the progress through the final quarter.

Pharma-Bio Serv, Inc. (OTC: PBSV) increased quarterly revenue by approximately $0.4 million to $2.3 million for the period ended July 31, 2026.

Nine-Month Revenue Reaches $7.3 Million

Revenue for the nine months ended July 31, 2026, was approximately $7.3 million, representing an increase of approximately $0.5 million from the same period last year. Pharma-Bio Serv recorded net income of approximately $252 thousand over the nine-month period, an improvement of approximately $352 thousand compared with the corresponding prior-year period. Its markets include Puerto Rico, the United States, Europe and Brazil.

Management Cites Progress Into Final Quarter

Chief Executive Officer Victor Sanchez said the quarterly results reflected client relationships and specialized regulatory and compliance capabilities. He said Pharma-Bio Serv had focused on markets where its expertise creates a Competitive Advantage and continued efforts to improve operating efficiency.